HilleVax, Inc.·4

Feb 2, 4:05 PM ET

McLoughlin Sean 4

4 · HilleVax, Inc. · Filed Feb 2, 2024

Insider Transaction Report

Form 4
Period: 2024-01-31
McLoughlin Sean
Chief Operating Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-01-31+250,000250,000 total
    Exercise: $14.17Exp: 2034-01-30Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]The option is exercisable as it vests. The option will vest with respect to 25% of the shares of common stock on January 29, 2025, and will vest with respect to the remaining shares in equal monthly installments over the following three years subject to the reporting person's continuous service to the Issuer on the applicable vesting dates.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4